System and method for reshaping heart

Abstract

The present teachings provide systems, devices, and methods for reshaping the heart and reducing valve regurgitation. A device can be positioned proximate the heart and have a delivery profile and an inflated profile. The device can have a primary cavity and a secondary cavity, and an adhesive inside the secondary cavity. An injectable medium can be injected to the primary cavity of the device. As the primary cavity is filled, the adhesive is forced out of the secondary cavity to adhere the device. The inflated device can exert pressure on the heart, change the shape of a valve annulus, and allow a better coaptation of the valve leaflets.

Description

FIELD

The present teachings generally relate to an inflatable device, and its use in reshaping the right heart, reducing tricuspid regurgitations, or/and delaying progression of heart failure due to tricuspid regurgitation.

BACKGROUND

Tricuspid valve diseases relate to conditions in which the valve between the two right heart chambers (i.e., the right ventricle and the right atrium) doesn't function properly and these diseases often occur with other heart valve problems. Examples of the tricuspid valve diseases include tricuspid valve regurgitation, tricuspid valve stenosis, tricuspid valve atresia, and the Ebstein's anomaly. In the tricuspid valve regurgitation, the tricuspid valve doesn't close properly and blood flows back into the right atrium; in the tricuspid valve stenosis, the tricuspid valve is narrowed and reduces the amount of blood flowing into the right ventricle; in the tricuspid atresia, a congenital heart disease, a solid wall of tissues blocks the blood from flowing between the two right heart chambers; and in the Ebstein's anomaly, a malformed tricuspid valve situates at a position lower than the normal position in the right ventricle and causes blood to flow back into the right atrium. There are other tricuspid valve diseases generally known to a person with ordinary skill in the art and these tricuspid valve diseases are also included in the present teachings.

A tricuspid valve disease can be corrected by an annuloplasty ring. In some instances, this device is preferred for surgically repairing a defective tricuspid valve. An annuloplasty ring is an anatomically-correct three-dimensional (3D) ring and can flexibly conform to the heart valve opening. This ring is implanted into a defective tricuspid valve and reduces the valve opening. Properly implanted, an annuloplasty ring allows the valve to open and close properly.

Tricuspid valve repair surgeries can be done in one of the following two ways: a minimally invasive surgery or an open-heart surgery. A minimally invasive method involves making a small incision in the upper or lower chest and inserting a valve repairing system/device percutaneously. After the valve is repaired, the incision is closed with dissolving sutures. Comparing to an open-heart surgery, advantages of a minimally invasive approach include a shorter recovery time, less post-operation pain, and earlier return to work and normal daily activities.

However, there are drawbacks in valve replacement therapies and, as a result, needs exist for repairing a diseased tricuspid valve percutaneously.

SUMMARY

One aspect of the present teachings provides a device configured to be positioned against a right heart. The device has a collapsed delivery profile and an inflated deployment profile. The flexible outer layer is configured to prevent moisture and gas from crossing the flexible outer layer. The device comprises a flexible outer layer encasing a cavity. The cavity is configured to be filled with an injection medium. The device further includes an injection port configured to be used to allow the injection medium enter into the cavity.

In one embodiment, the device has a portion of the flexible outer layer which inflates to a greater extent than the rest of the flexible outer layer.

In another embodiment, the flexible outer layer further comprises a first component and a second component, wherein the first component and the second component are binding together to form a waist. The first component is configured to be positioned against the right atrium. The second component is configured to be positioned against a right ventricle. The waist is configured to be positioned outside of the tricuspid annulus. In its deployed configuration, the waist of the flexible outer layer inflates to a less extent than the first and second components.

Another aspect of the present teachings provides a device configured to be positioned against a right heart, wherein the device has a collapsed delivery profile and an inflated deployment profile. The device comprises a flexible outer layer encasing a primary cavity and a secondary cavity radially outside of the primary cavity. The primary cavity is configured to be filled with an injection medium. The secondary cavity is configured to be filled with tissue binding adhesives. A barrier separates the primary and second cavities, preventing moisture and gas from crossing the barrier. And a portion of the flexible outer layer outside of the secondary cavity has a plurality of pores, allowing the tissue binding adhesive to exit the secondary cavity to the outside of the flexible outer layer.

In one embodiment, when filled with injection medium, the barrier separating the primary and second cavities expands to a greater extent than the portion of the flexible outer layer outside of the secondary cavity.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 is a perspective view of an embodiment of the present teachings where an inflatable balloon is positioned against the right heart free wall according to the present teachings.

FIG. 2 is a perspective view of an embodiment of the present teachings where a needle is used to puncture subxiphoid to access the treatment space according to the present teachings.

FIG. 3 is an embodiment of the inflatable balloon in its delivery profile and attached to a delivery system in accordance with the present teachings.

FIG. 4 is an embodiment of the inflatable balloon positioned against the right heart free wall according to the present teachings.

FIG. 5 is an embodiment of the inflatable balloon in its delivery profile according to the present teachings.

FIG. 6 is an embodiment of the inflatable balloon in its delivery profile according to the present teachings.

FIG. 7 is an embodiment of the inflatable balloon in its delivery profile according to the present teachings.

FIG. 8 is an embodiment of the inflatable balloon attached to a delivery system in accordance with the present teachings.

FIG. 9 is an embodiment of the inflatable balloon disengaging from a delivery system in accordance with the present teachings.

FIG. 10 is a perspective view of an embodiment of the present teachings where an inflatable balloon is delivered to the treatment location via a delivery system.

FIG. 11 is a perspective view of an embodiment of the present teachings where an inflatable balloon is deployed at the treatment location via a delivery system.

FIG. 12 is a perspective view of an embodiment of the present teachings where an inflatable balloon is deployed at the treatment location via a delivery system.

DETAILED DESCRIPTION

Certain specific details are set forth in the following description and figures to provide an understanding of various embodiments of the present teachings. Those of ordinary skill in the relevant art would understand that they can practice other embodiments of the present teachings without one or more of the details described herein. Thus, it is not the intention of the Applicant(s) to restrict or in any way limit the scope of the appended claims to such details. While various processes are described with reference to steps and sequences in the following disclosure, the steps and sequences of steps should not be taken as required to practice all embodiments of the present teachings.

As used herein, the term “lumen” means a canal, a duct, or a generally tubular space or cavity in the body of a subject, including a vein, an artery, a blood vessel, a capillary, an intestine, and the like. The term “lumen” can also refer to a tubular space in a catheter, a sheath, a hollow needle, a tube, or the like.

As used herein, the term “proximal” shall mean close to the operator (less into the body) and “distal” shall mean away from the operator (further into the body). In positioning a medical device inside a patient, “distal” refers to the direction away from a catheter insertion location and “proximal” refers to the direction close to the insertion location.

As used herein, the term “wire” can be a strand, a cord, a fiber, a yarn, a filament, a cable, a thread, or the like, and these terms may be used interchangeably.

As used herein, the term “sheath” may also be described as a “catheter” and, thus, these terms can be used interchangeably.

Unless otherwise specified, all numbers expressing quantities, measurements, and other properties or parameters used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless otherwise indicated, it should be understood that the numerical parameters set forth in the following specification and attached claims are approximations. At the very least and not as an attempt to limit the application of the doctrine of equivalents to the scope of the attached claims, numerical parameters should be read in light of the number of reported significant digits and the application of ordinary rounding techniques.

The present teachings relate to devices and methods for treating a tricuspid valve regurgitation percutaneously. A person with ordinary skill in the art would recognize that the figures and description thereto refer to various embodiments of the present teachings and, unless indicated otherwise by their contexts, do not limit the scope of the attached claims.

An aspect of the present teachings relates to methods of reducing the size of the right heart, and subsequently reducing the tricuspid regurgitation. In various embodiments, the method includes deploying a balloon (10) through a percutaneous subxiphoid approach to the outside of the pericardium (2) as illustrated in FIG. 1. The balloon (10) squeezes the right side of the heart, both the right atrium (RA) and the right ventricle (RV). As a consequence, the tricuspid annulus changes it shape, which leads to more coaptation among the leaflets of the tricuspid valve (5).

In various embodiments, the balloon is positioned inside or outside of the pericardium. In various embodiments, the balloon is positioned approximately to the anterior and posterior commissure with a small portion, such as 30%, against the right atrium and a relatively larger portion against the right ventricle. In various embodiments, the balloon is anchored to the sternum. In various embodiments, the balloon is shaped to be self-anchoring, self-aligning, or self-stabilizing. In some embodiments, the balloon in its deployed configuration includes an indentation. In certain embodiments, the indentation is in a shape of wedge. In certain embodiments, the indentation is configured to fit the heart into the wedge when the balloon is in its deployed configuration. In particular embodiments, the wedge pushes posteriorly on the anterior portion of the right heart. In particular embodiments, the balloon is stabilized between the heart and the sternum by the wedge cupping with the right heart.

FIG. 2 illustrates insertion of a needle (8) to the space between the heart and the sternum. According to some embodiments of the present teachings, the access to the space is done through a subxiphoid approach. The procedure starts with a small vertical incision to the left of the subxiphoid. A puncture through the skin and subcutaneous tissue is made straight or at a 45-degree angle pointing toward the right shoulder. One skilled in the art should understand that the puncture is done by using a Tuohy needle, with appropriate endocardial and/or fluoroscopy guidance. Additionally contrasts should be used to ascertain the puncture location.

In various embodiments, access for an insertion catheter is created through a needle and wire exchange. In some embodiments, a needle is used to puncture the chest cavity starting from below the xiphoid process and angling the needle superior and left. In some embodiments, a needle is used to puncture the chest cavity through the 5th or 6th intercostal space on the left side of the sternum. In some embodiments, once a needle is passed through the sternum, a wire is advanced through the needle into the space between the sternum and the pericardial sac. In various embodiments, the wire is specially designed to help remove any adhesions between the pericardium and the sternum. In some embodiments, the wire is left behind and the needle is removed. In various embodiments, an insertion catheter is advanced over the wire and into the target region of the anatomy. In some embodiments, the insertion catheter includes a dilating sheath or dilating tip designed to increase the diameter of the needle hole. In some embodiments, a separate dilating member is used prior to insertion of the catheter. In some embodiments, a fluid is injected into the target space of the anatomy in order to facilitate the subsequent inflation of the bladder. In some embodiments, the fluid is saline or nitrogen gas. In some embodiments, the fluid includes a biocompatible, bio-resorbable lubricant.

In various embodiments, access for an insertion catheter is accomplished through a novel modification of a pericardiocentesis kit. In some embodiments, a needle is advanced through the sternum and through the pericardium as is commonly done to aspirate effusions from the pericardium. In some embodiments, a wire is advanced through the needle and into the pericardial space and the needle is retracted out of the body. In some embodiments, an access catheter is advanced over the wire. In various embodiments, the access catheter is designed with a blunted tip such that it passes through the sternum but does not dilate the hole in the pericardium created by the needle. In some embodiments, the access catheter is advanced through the sternum and up to but not through the pericardium. In some embodiments, the wire is withdrawn and the catheter is repositioned in order to deliver the balloon.

In various embodiments, the delivery of the access catheter is aided by fluoroscopy, transesophageal echocardiography, or transthoracic echocardiography. In some embodiments, the delivery catheter or delivery system includes piezo electric elements designed to function as a specially designed echo probe. In some embodiments, the access catheter delivery system is designed to engage a separate and commercially available TTE probe for imaging assistance during the procedure.

In various embodiments, the access to the space between the pericardium and the heart chambers is facilitated by an indwelling catheter in the right heart. In some embodiments, the right heart catheter is designed to create a small puncture in the right atrial appendage. In some embodiments, the right heart catheter is used to inject a predetermined amount of saline or other fluid into the pericardial space. In some embodiments, the fluid is echogenic. In some embodiments, the fluid is used to create separation between the right heart and the pericardium. In some embodiments, the fluid is injected into the pericardium and then aspirated back through the access catheter or through the right heart catheter. In some embodiments, a space is created between the pericardium and the right heart by a right heart catheter. In certain embodiments, the right heart catheter is designed to grasp a portion of the right heart, for example, the right atrial appendage, or the anterior wall of the right atrium. In some embodiments, the right heart catheter is designed to grasp the anterior wall of the right heart above the plane of the right coronary artery. In certain embodiments, the right heart catheter is retracted by 2-3 cm in order to create some space between the pericardium and the right heart.

In various embodiments, the distal end of the insertion needle (8) is positioned outside of the pericardium. In other embodiments, the distal end of the insertion needle (8) is further advanced slightly to puncture the pericardium and reach inside the pericardial space.

Another aspect of the present teachings provides an inflatable balloon (10) that can be deployed at a treatment location, as shown in FIG. 4. In various embodiments, the inflatable balloon (10) has a cavity (37) (FIG. 5) encased by at least one layer of a flexible material. In some embodiments, the inflatable balloon (10) has a delivery state where it is housed and delivered through a delivery system (20) as shown in FIG. 3. In one embodiment, the delivery system (20) includes an access sheath (22), a delivery catheter (24), and an injection catheter (26). In some embodiments, the inflatable balloon (10) has a deployed state, where it is filled with an injectable medium, such as a liquid, a gel, a gas, foam, or another medium. In some embodiments, the delivery state of the inflate balloon (10) is referred to as a state where the device is completely free of injectable medium. Alternatively, in some embodiments, the balloon (10) is partially filled with some injectable medium. In some embodiments, any state that is greater in size than the delivery state is considered to be a deployed state.

In various embodiments, as shown in FIG. 4, at its deployed state, the balloon (10) is positioned against the right heart anterior free wall approximate to the outside of the tricuspid valve (5) annulus location. As shown in FIG. 4, a portion of the balloon (10) is placed and compresses against the right atrium, and another portion of the balloon (10) is placed and compresses against the right ventricle. In some embodiments, the balloon (10) at its deployed state is configured to compress the right side of the heart, changes the profile of the tricuspid annulus, and, as a result, improves the coaptation of the tricuspid leaflets and reduces tricuspid regurgitation. One skilled in the art should understand that the deployed state of the balloon (10) could vary from a patient to another patient due to the individual anatomy and the amount of compression needed to achieve a reduction in tricuspid regurgitation. Thus, the amount of the medium injected inside the cavity (37) of the inflatable balloon (10) is determined based on each patient's needs and controlled by a clinician.

According to some embodiments, the medium filled inside the cavity (37) of the balloon (10) could be an injectable medium, such as a liquid, a hydrogel, a gas, or foam. In an embodiment, other materials or structures, that is capable of maintaining its volume as well as changing its shape to conform to the anatomic space at the implanting location while under compression, could also be used. In another embodiment, the injectable medium is capable of reducing its volume while under compression, and increasing its volume after the compression is removed, for example, a material capable of undergoing a phase change from a first volume to a second volume at the temperature and/or pressure ranges inside a body cavity (37) may also be used.

Now referring to FIG. 5, where an exemplary embodiment of an inflatable balloon (30) is illustrated in its deployed profile. In various embodiments, the inflatable balloon (30) comprises a flexible wall (32) and an injection port (34). In various embodiments, the flexible wall (32) is configured to transfer the pressure from the inside to the outside of the balloon (10). As a result, in some embodiments, the inflatable balloon (10) exerts a force to the heart. In various embodiments, the flexible wall (32) is flexible. In some embodiments, the flexible wall (32) allows shape change of the balloon (30) while the balloon (30) is exposed to an external pressure from the anatomy. In various embodiments, the flexible wall (32) is stiff enough to hold the pressure exerted by the medium inside the balloon (30).

Continue referring to FIG. 5, according to some embodiments, the injection port (34) joins, releasably, a medium injection catheter (26) (See, FIG. 3). As later described, in some embodiments, once joined, the injection catheter (26) is configured to push, pull, or otherwise manipulate the inflatable balloon (30). In some embodiments, the injection catheter (26) is configured to deliver a medium into the cavity (37) of the balloon (30).

According to some embodiments, the flexible wall (32) of the device comprises at least one gas barrier layer. According to some embodiments, the flexible wall (32) comprises at least one moisture barrier layer. According to some embodiments, the gas barrier layer and moisture barrier layer are laminated together. In some embodiments, the gas barrier is constructed as an external layer of the flexible wall (32). In some embodiments, the moisture barrier is constructed as an internal layer of the flexible wall (32). In other embodiments, the moisture barrier is constructed as an external layer of the flexible wall (32). In other embodiments, the gas barrier is constructed as an internal layer of the flexible wall (32). In other embodiments, the gas barrier material and moisture barrier material are blended together to form a single barrier layer. Yet in other embodiments, more than one layer of the gas barrier and/or more than one layer of the moisture barrier layer are incorporated. In some embodiments, the more than one layer of the gas barrier and the more than one layer of the moisture barrier layer are arranged in an alternating manner. In yet other embodiments, any other arrangements are equally applicable as long as they are suitable for the purpose of the present teachings and their manufacturing capability.

A variety of gas barrier materials, including polyvinylidene chloride, ethyl vinyl alcohol, fluoropolymers, or etc., can be used for constructing a device of the present teachings. Gas barrier materials are generally relatively stiff, have high moisture vapor permeability, and low impact strength. Consequently, a layer of flexible material with high moisture barrier and high impact strength should also be incorporated into the flexible wall (32) of the device.

A variety of moisture barrier materials, including polyamide, polyethylene, polypropylene, polyurethane, polyamide/polyester copolymer, polystyrene/polybutadiene copolymer, and etc., can be used for constructing a device of the present teachings. The moisture barrier materials are generally flexible and have high impact strength.

In some embodiments, an additional reinforcement layer is incorporated into the flexible wall (32) in order to enhance the structural integrity of the device. In some embodiments, the reinforcement layer has high impact strength. In certain embodiments, the reinforcement layer is made of a polymer, including polyurethane, EVA, PE, polypropylene, or silicone. In various embodiments, the reinforcement layer is an external layer of the flexible wall (32). In various embodiments, the reinforcement layer is an internal layer of the flexible wall (32). In various embodiments, the reinforcement layer is a middle layer of the flexible wall (32). In some embodiments, the flexible wall (32) includes more than one reinforcement layer. In certain embodiments, at least one of the more than one reinforcement layers is between a gas barrier layer and a moisture barrier layer.

In some embodiments, the device have three, four, five, or more layers including a gas barrier layer, a moisture barrier layer, and one or more reinforcement layers. In some embodiments, the device has multiple gas barrier layers and/or multiple moisture barrier layers, arranged in a sequential or non-sequential arrangement.

In various embodiments, the overall thickness of the flexible wall (32) is preferably minimized. In some embodiments, the overall thickness of the flexible wall (32) ranges between 0.003 to 0.03 inches. In some embodiments, each layer of the flexible wall (32) has a same thickness. In some embodiments, at least two layers have different thickness. In certain embodiments, each layer of the flexible wall (32) has a different thickness from the other layers.

The layers of the flexible wall (32) can be made in any number of ways known to those skilled in the art, including, but not limited to, lamination, co-extrusion, dip molding, spray molding, or the like. In various embodiments, the flexible wall (32) is made by laminating two or more layers together. Lamination can be achieved through many techniques known to those skilled in art. In some embodiments, the lamination is achieved by using heating, solvents, adhesives, tie layers, or other like methods.

One skill in the art would understand that the material used to construct the flexible wall (32) of the device is sufficiently flexible in the thickness ranges selected for the present teachings. Since the device is subject to external pressures, the device's material in various embodiments is able to transmit the pressure from the sternum to the right heart. In various embodiments, the material used to construct the flexible wall (32) is selected to produce an appropriate compression to the right heart. In various embodiments, the pressure and volume of the inflation medium (injection medium) is selected to produce an appropriate compression to the right heart. For example, in its deployed profile, the device is sufficiently stiff to compress the right heart. In some embodiments, the compression leads to a change of the profile of the tricuspid annulus. In some embodiments, the device is flexible enough to accommodate the right heart expansion during the diastolic cycles.

According to some embodiments, the right heart pressure, such as the right ventricle pressure, is closely monitored during the balloon expansion in order to prevent from over-pressuring the right heart. For example, during the balloon expansion, the pulmonary capillary wedge pressure (PCWP) can be monitored and the PCWP can sometimes serve as a good indicator for the right ventricle pressure. When it shows that the right ventricle is over pressured, for example, beyond 40 mmHg, a clinician can deflate the balloon.

According to some other embodiments of the present teachings, the balloon is designed in such way that after deployed, it can still be reattached to a catheter in order to further inflate or deflate the balloon to achieve the optimum treatment result. For example, a balloon can include an injection port which can be reattached by an injection catheter after the procedure. In another example, a balloon can also include a lead which can be left behind and used to be re-attached for pressure adjustment after the procedure.

According to other embodiments of the present teachings, a pumping mechanism between the components of the balloons is also incorporated in the design in order to allow fluid transfer between the components. In some embodiments, such pumping mechanism allows pressure adjustment in each component of the balloon and can be used to avoid over pressuring certain part of the heart, or create a messaging effect to the heart.

In some embodiments, the flexible wall (32) comprises a continuous layer of material. In some embodiments, such as FIG. 6, the flexible wall (42) comprises a first component and a second component, where the first and second components are bonded together. Once injected with the medium, the first component and second component of the balloon (40) expands, while the bonding seam between the first component and second component, remains unchanged, or only slightly stretched, forming a waist in its deployed profiled, such as shown in FIG. 6. In some embodiments, the bonding seam is configured to be positioned outside of the tricuspid valve (5) annulus.

One skilled in the art should understand that the two components can be identical or different in sizes. In some embodiments, the components to be deployed against the right ventricle are larger than the component to be deployed against right atrium. According to some embodiments, the seams are accomplished in any of a variety of manners known to those skilled in the art. In certain embodiments, the bonding of the two components are achieved by using heat bonding, chemical bonding, mechanism bonding, and the like. One skilled the art should understand that more than two components can be included in forming the device. Thus, the embodiments disclosed herein should not be viewed as limiting.

According to some embodiments, once injected with a medium of the present teachings, the balloon (10) device as illustrated in FIGS. 5-6 expand evenly in all directions. In other embodiments, the expansion of the balloon (10) is controlled with the most expansion inwardly toward the heart, and less or no expansion in other directions so that once deployed, the portion of the balloon (10) facing the heart wall expands and compresses the right heart.

According to some embodiments of the present teachings, the balloon is expanded in a sequential motion with one component expanding after another. In other embodiments of the present teachings, the balloon expansion is controlled by a dynamic pulse control, such that one component is expanded with a long pulse, and another component is expanded with a high pulse. One skilled in the art should understand that balloon expansion can be achieved by many other ways, and the exemplary approaches described herein should not be viewed as limiting to the scope of the present teachings.

In some embodiments, once inflated, the balloon (10) has an overall width of 2 mm-4 cm and an overall height of 4 mm-6 cm. In some embodiments, the portion of the balloon (10) against the right ventricle is greater than the portion of the balloon (10) against the right atrium.

In various embodiments, the balloon is designed to be compliant only up to a predetermined size and shape. After the balloon is inflated to this shape by the injectable fluid, the balloon resists further inflation. In some embodiments, the resistance to additional inflation is accomplished by the composite construction of the balloon. In some embodiments, the wall of the balloon includes fibrous members such as suture material, braided polyester fibers, nylon strands, or other materials. In some embodiments, the bladder is loosely defined as a non-compliant balloon. In some embodiments, the bladder is designed to inflate in a stepwise manner. In various embodiments, in the first step, the bladder is designed to expand in a manner that is largely flat, expanding along the contact surface of the right heart and the sternum. In some embodiments, as the inflation pressure increases and the largely flat expansion of the balloon nears its final size, the balloon expands largely by increasing in thickness. In some embodiments, the balloon includes two fluid sealed cavities/chambers. In some embodiments, the first cavity/chamber includes a large flat shape which contours to the wall of the sternum and to the shape of the heart. In some embodiments, the second cavity/chamber is designed to expand largely in the thickness dimension, thereby pushing against the sternum and the heart but not expanding in other directions.

According to various embodiments (e.g., FIG. 5), the injection port (34) of the device includes an injection tube (36) and a valve (38). The injection tube (36) creates a fluid communication path between the interior cavity (37) and the injection catheter (26). The valve (38) is configured to permit one way flow through the injection tube (36). Upon removal of the injection catheter (26), the valve (38) closes automatically and prevents the escape of the injection medium from the interior cavity (37) through the injection tube (36).

According to some embodiments, the injection tube (36) has a connected end joining to the flexible wall (32) and a free end (35) extending into the cavity (37) of the balloon (10). In certain embodiments, the tube includes a tubular lumen (33) extending from the connected end to its free end (35). The tubular lumen (33) forms a flow path for the injection medium to be delivered inside the cavity (37) of the balloon (10). In other embodiments, the valve (38) is positioned inside the tubular lumen (33) of the Tube. Although FIG. 5 illustrates a valve (38) in the middle portion of the tubular lumen (33), one skilled in the art would understand that the valve (38) can be at or near the connected end of the injection tube (36), at or near the free end (35) of the injection tube (36), or anywhere inside the lumen between the connected and free end (35) of the injection tube (36).

According to various embodiments, the injection tube (36) is made of polyethylene, Pebax, polyurethane, etc. In various embodiments, the injection tube (36) is made by a known technique in the field. In some embodiments, the injection tube (36) is made by extrusion. According to various embodiments, the valve (38) and flap are made from a flexible material such as polyurethane, silicone, or polyethylene. According to some embodiments, the bonding between the valve (38) and tube, the tube and the flexible wall (32) of the balloon (30), and the flap and the tube is achieved by a known technique in the field. In certain embodiments, the bonding is achieved through a mechanical means. In particular embodiments, the bonding is through a screw, a bolt, a clamp, or the like. In certain embodiments, the bonding is achieved through a chemical means. In particular embodiments, the bonding is achieved through an adhesive or the like. In some embodiments, the bonding is achieved through a thermal means. In particular embodiments, the bonding is achieved by ultrasonic welding, laser welding, overmolding, or the like. Other attachment methods known to the skilled artisan can also be used.

According to various embodiments of the present teachings, upon the device being filled with the medium content, the device resumes a predesigned deployed profile. In some embodiments, upon inflation, the device assumes a general spherical profile, a pillow profile, or a snow man profile with a waist. One skilled in the art should understand that an inflated device can assume any profile that is suitable for its intended function.

According to various embodiments, the valve (38) inside the injection tube (36) has a duckbill configuration. In some embodiments, the valve (38) includes a first and a second duck bill valve (38) leaflets which are attached to the tubular wall. In some embodiments, the leaflets extend in the direction toward the free end (35) of the injection tube (36) and form a pair of coaptive edges. This configuration allows a distal-direction flow to separate the coaptive edges, thereby enabling inflation of the device. Upon removal of the injection medium source, the inflation medium within the device in combination with the natural bias of the leaflets cause the leaflets to coapt, thereby preventing any proximal flow of medium through the flow path. One skilled in the art should understand that other suitable valve (38) design, such as tricuspid, flap, biased valve (38), known in the field could also be used here. Thus, the embodiments disclosed herein should not be viewed as limiting to the overall scope of the present teachings.

FIG. 7 illustrates another embodiment of the present teachings, where the balloon (50) further includes a binding mechanism that is configured to secure a deployed balloon (50) at a treatment location. As shown in the figure, the inflatable balloon (50) has two cavities. The primary cavity (54) is configured to be filled with an inject medium which causes the balloon (50) to expand. The secondary cavity (52) is configured to contain a bio-adhesive. And the secondary cavity (52) is located radially outside of the primary cavity (54) as shown. According to one embodiment, the secondary cavity (52) is located radially outside of the primary cavity (54). A barrier (56) exists between the primary and secondary cavities (52), which prevents the injection medium from exiting the primary cavity (54) and entering the secondary cavity (52). According to some embodiments, the secondary cavity (52) is covered with an external stretchable and porous layer (58). Similar to the previous embodiments, the balloon (50) includes an injection port (64), an injection tube (36) and a valve (68) disposed within the injection tube (36).

When the balloon (50) is in its delivery collapsed profile, the adhesive is stored inside the secondary cavity (52). The delivery system carries the collapsed balloon (50) into the treatment location. Once the balloon (50) is filled with injection medium, as the balloon (50) expands, the external porous layer (58) outside of the secondary cavity (52) also stretches, allowing the pores to be opened up. As the balloon (50) further expands, it squeezes the adhesive, letting it exit the pores (62). The adhesive is configured to bond the balloon (50) with the sternum.

In some embodiments, when filled with the injection medium, the barrier (56) separating the primary and second cavities (54, 52) expands more than the portion of the flexible outer wall outside of the secondary cavity (52). As a result, the difference in stretchability would allow the primary cavity (54) to expand at a greater rate than the secondary cavity, thereby pushing the tissue binding adhesive out of the pores (62) in the flexible wall (58).

In some embodiments, the balloon (50) is designed such that under certain inflation pressures, the adhesive remains inside the secondary cavity (52). Once a clinician is satisfied with the deployment and/or apposition, the balloon (50) is inflated to a final pressure and the adhesive is then pushed out to the external surface (58). In some embodiments, the adhesive is activated upon being exposed to the moisture of the anatomy.

According to one embodiment of the present teachings, the secondary cavity is configured to be positioned approximately to the right ventricle, so that after an adhesive is applied to the exterior surface, the balloon is bonded to the right ventricle. In another embodiment, the secondary cavity is configured to be positioned approximately to the right atrium, so that the adhesive is used to bond the balloon to the right atrium of the heart.

FIG. 8 further illustrates a balloon delivery system configured to join the balloon (40) at its injection port (44). In various embodiments, the balloon delivery system controls the movement of the balloon (40) and injects the inflation medium into the cavity (47) of the inflatable balloon (40). According to some embodiments, the balloon delivery system comprises an elongate delivery catheter (24) having a proximal end and a distal end. The delivery catheter (24) is configured to slide through an access sheath (22) (not shown) placed at the treatment location. Thus, the delivery catheter (24) preferably has an outside diameter of no more than about 8 mm. The length of the delivery catheter (24) may vary, depending upon each patient. In general, an axial length of delivery catheter (24) is within the range of from about 1″ to about 10″ for adult patients.

According to various embodiments, the delivery catheter (24) has a central lumen extending axially therethrough. The central lumen axially slideably receives an injection catheter (26) for filling the balloon (40). The injection catheter (26) comprises a tubular body having a proximal end, a distal end, and a medium injection lumen extending throughout the length from its distal end to a proximal hub where a connector is typically used for coupling the proximal hub to a source of inflation medium.

According to various embodiments, the injection catheter (26) extends distally, or retracts proximally, independent of the delivery catheter (24). The distal end of the injection catheter (26) has a generally tubular shape and is configured to be positioned within the valve (48) inside the injection port (44) of the balloon (40). The distal end of the delivery catheter (24) is dimensioned such that it fits through the injection port (44) of the balloon (40). In some embodiments, the delivery catheter (24) further includes a distal stop surface configured to stop the proximal movement of the device as shown in FIG. 8.

FIG. 8 illustrates an embodiment of the present teachings where the balloon delivery system is fully engaged with the balloon (40). As illustrated, the distal end portion of the injection catheter (26) is fit inside the injection tube (46) and positioned across the valve (48). In some embodiments, the distal end portion of the injection catheter (26) is capable of opening the valve (48). The distal end of the injection catheter (26) is within the injection tube (46) and distal to the valve (48). The distal end of the delivery catheter (24) contacts the proximal end of the injection tube (46). In some embodiments, the balloon (40) is pushed distally, retracted proximally, torqued radially, and otherwise manipulated by the balloon delivery system.

In various embodiments, the valve (48) inside the injection tube (46) of the balloon (40) has a mechanism that prevents the injection medium from back-flowing to the outside of the balloon (10). According to some embodiments, once the injection catheter (26) is placed inside the injection port (44), a clinician can inject the inflation medium into the cavity (47) of the balloon (40).

After the balloon (40) is inflated to a desired size, a clinician in various embodiments stops the medium injection and removes the injection catheter (26). As shown in FIG. 9, with the delivery catheter (24) remains steady, the injection catheter (26) can be withdrawn proximally and exit the injection port (44) of the balloon (40). The one-way valve (48) inside the injection port (44) closes automatically and seals the injection medium inside the balloon (40).

FIGS. 10-11 illustrate a deployment process of the balloon (10). As shown in FIG. 10, an access sheath (22) is first placed at the treatment location following a subxiphoid puncture described above. According to some embodiments, the access sheath (22) is used to slideably carry the balloon delivery system assembly. In some embodiments, the balloon delivery system assembly slides from a proximal end of the access sheath (22) to its distal portion after proper placement of the access sheath (22). In some embodiments, during delivery, the deflated balloon (10) is rolled around a distal end portion of the injection catheter (26) and carried within the tubular lumen of the access sheath (22) during the placement.

As shown in FIG. 10, once the system is properly positioned, the access sheath (22) is retracted proximally with respect to the balloon delivery system (20) in order to expose the deflated balloon (10). A medium is then introduced distally from the proximal hub of the injection catheter (26) to inflate the balloon (10) to an intended degree.

Following the inflation of the balloon (10), as shown in FIG. 11, the injection catheter (26) is disengaged from the injection port (34) of the balloon (10) by retracting the injection catheter (26) with respect to the delivery catheter (24). A distal stop surface on the delivery catheter (24) prevents the proximal movement of the balloon (10) as the injection catheter (26) is proximally retracted. The balloon delivery system (20) is thereafter removed from the patient, leaving the inflated balloon (10) within the body.

In various embodiments, the balloon device expands in a step-wise fashion. In some embodiments, the balloon device expands to a first length. In some embodiments, the balloon device expands to a first width. In some embodiments, the balloon expands to a first length first and a first width second. In some embodiments, the balloon expands to a first width first and a first length second. In certain embodiments, the first length is predetermined. In certain embodiments, the first length is adjustable according to the patient's need. For example, as shown in FIG. 12, the first length can be approximately the length of the pericardial cavity. In another example, as shown in FIG. 12, the width can be the width of the pericardial cavity. In some embodiments, the first width varies along the length of the balloon. As such, in certain embodiments, the balloon expands inwardly toward the right atrium. In certain embodiments, the balloon expands inwardly toward the right ventricle. Although FIG. 12 shows a particular length and width of a balloon device, one with ordinary skill in the art would understand that the length or/and the width of the balloon device can be greater or less than what are shown in FIG. 12.

One skilled in the art should understand that the devices disclosed above are merely embodiments of the present teachings. For example, the balloons illustrated in the drawings show only one injection port for inflation. One skilled in the art should understand that more than one injection ports can be incorporated in the balloon design without departing from the scope of the present teachings. In another example, the implantation of the balloon at a desired treatment site is done through a subxiphoid puncture procedure. An alternative to such implantation route can be to insert the balloon into the right atrium through a standard right heart catheterization procedure followed by a puncture to the heart wall from inside the right atrium. A further alternative can be to insert the balloon into the right atrium, then to extend through the tricuspid valve into the right ventricle, and finally to puncture through the right ventricular wall. Other alternative implantation route(s) can also be incorporated, and all of which should be considered as part of the present teachings.

The methods and devices disclosed above are useful for treating one or more symptoms of tricuspid regurgitation, by reducing the right heart size. One skilled in the art would further recognize that devices according to the present teachings could be used to treat various symptoms of mitral regurgitation. For example, the devices disclosed herein can be deployed against the left heart.

Various embodiments have been illustrated and described herein by way of examples, and one of ordinary skill in the art would recognize that variations can be made without departing from the spirit and scope of the present teachings. The present teachings are capable of other embodiments or of being practiced or carried out in various other ways. Also, it is to be understood that the phraseology and terminology employed herein is for the purpose of description and should not be regarded as limiting.

Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this present teachings belong. Methods and materials similar or equivalent to those described herein can be used in the practice or testing of the present teachings. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and not intended to be limiting.

Claims

1. A system comprising: an access sheath, configured to be introduced to a treatment location outside a heart of a subject;a delivery catheter;a device configured to be positioned at the treatment location, against a right side of the heart, the device comprising: a tissue-binding adhesive;a flexible outer layer encasing a primary cavity and a secondary cavity outside of the primary cavity, a portion of the flexible outer layer outside of the secondary cavity having a plurality of pores between the secondary cavity and the outside of the flexible outer layer;a barrier separating the primary and secondary cavities, inhibiting moisture from crossing the barrier; andwherein the device has a collapsed delivery profile and an inflated deployment profile, and in the collapsed delivery profile, the device is dimensioned to be advanced, within the access sheath, to the treatment location, while the secondary cavity contains the tissue-binding adhesive;wherein the device is inflatable to the inflated deployment profile by introducing an injection medium into the primary cavity, andwherein introducing the injection medium into the primary cavity forces at least some of the tissue-binding adhesive out of the secondary cavity via the pores.

2. The system according to claim 1, wherein the barrier separating the primary and secondary cavities expands more than the portion of the flexible outer layer outside of the secondary cavity when the injection medium is introduced into the primary cavity, thereby allowing the primary cavity to expand at a greater rate than the secondary cavity, thereby forcing the at least some of the tissue-binding adhesive through the pores.

3. The system according to claim 1, wherein the device further includes a one-way valve disposed within an injection tube used to introduce the injection medium into the primary cavity.

4. The system according to claim 1, wherein the barrier extends longitudinally from a distal end to a proximal end of the device which is in the form of an inflatable balloon.

5. The system according to claim 1, wherein the secondary cavity is disposed alongside the primary cavity.

6. The system according to claim 1, wherein: the portion of the flexible outer layer outside of the secondary cavity is a first portion of the flexible outer layer that delineates at least part of the primary cavity, anda second portion of the flexible outer layer delineates at least part of the secondary cavity.

7. The system according to claim 1, wherein the primary cavity is configured to inflate into a flat shape.

8. The system according to claim 1, wherein the device further comprises an injection port configured to allow the injection medium to be introduced into the primary cavity.

9. The system according to claim 8, wherein the injection port comprises an injection tube that is disposed entirely within the primary cavity and is only in fluid communication with the primary cavity and not the secondary cavity, the injection port being configured for being detachably coupled to an inflation catheter.

10. A system comprising: a device configured to be positioned at a treatment location, against a right side of the heart, the device comprising: a tissue-binding adhesive;a flexible outer layer encasing a primary cavity and a secondary cavity outside of the primary cavity, a portion of the flexible outer layer outside of the secondary cavity having a plurality of pores between the secondary cavity and the outside of the flexible outer layer;a barrier separating the primary and secondary cavities, inhibiting moisture from crossing the barrier; andwherein the device has a collapsed delivery profile and an inflated deployment profile, and in the collapsed delivery profile, the device is dimensioned to be advanced through a catheter to the treatment location, while the secondary cavity contains the tissue-binding adhesive;wherein the device is configured such that injecting an injection medium into the primary cavity both inflates the device to the inflated deployment profile and forces at least some of the tissue-binding adhesive out of the secondary cavity via the pores.

11. The system according to claim 10, wherein the barrier separating the primary and secondary cavities expands more than the portion of the flexible outer layer outside of the secondary cavity when the injection medium is introduced into the primary cavity, thereby allowing the primary cavity to expand at a greater rate than the secondary cavity, thereby forcing the at least some of the tissue-binding adhesive through the pores.

12. The system according to claim 10, wherein the barrier extends longitudinally from a distal end to a proximal end of the device which is in the form of an inflatable balloon.

13. The system according to claim 10, wherein the secondary cavity is disposed alongside the primary cavity.

14. The system according to claim 10, wherein: the portion of the flexible outer layer outside of the secondary cavity is a first portion of the flexible outer layer that delineates at least part of the primary cavity, anda second portion of the flexible outer layer delineates at least part of the secondary cavity.

15. The system according to claim 10, wherein the primary cavity is configured to inflate into a flat shape.

16. The system according to claim 10, wherein the device further comprises an injection port configured to allow the injection medium to be introduced into the primary cavity.

17. The system according to claim 16, wherein the injection port comprises an injection tube that is disposed entirely within the primary cavity and is only in fluid communication with the primary cavity and not the secondary cavity, the injection port being configured for being detachably coupled to an inflation catheter.

18. The system according to claim 17, wherein the device further includes a one-way valve disposed within the injection tube used to introduce the injection medium into the primary cavity.